From June 17th to 18th, the Vape Club Show Moscow, an e-cigarette exhibition, was held at the Crocus Expo Center in Moscow. As the official media partner of the exhibition, 2FIRSTS provided comprehensive on-site coverage of the event.
During the exhibition, 2FIRSTS conducted an interview with Evgeny, the marketing manager for the Russian market of the e-cigarette brand INFLAVE. He stated that INFLAVE entered the Russian market in 2021 and is currently one of the top five e-cigarette brands in the market. Their main products are disposable e-cigarettes and e-liquids. The disposable e-cigarettes come in both large and small quantities, and they also have zero-nicotine products.
INFLAVE Exhibition Scene Photo | Image Source: 2FIRSTS
Regarding the question of which is more popular in the market, disposable or open e-cigarettes, Yevgeny believes that the demand for disposable e-cigarettes is still on the rise, while open e-cigarettes show relatively weaker performance.
Furthermore, Yevgeny states that in his opinion, the new e-cigarette policies in Russia will not have a significant impact on the market. This is because the sale of these products to minors has always been prohibited in Russia. As a brand, they support the legalization of the market.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
